Search results
Despite its 'nothingburger' reputation, COVID-19 remains deadlier than the flu
LA Times via Yahoo News· 15 hours ago“And among those hospitalized, more will die as a result.” Yet Al-Aly noted with frustration that...
Too many Australians aren't getting a flu vaccine—why, and what can we do about it?
Medical Xpress· 3 days agoLooking back over recent years, for kids aged 6 months to 5 years, we saw a peak in flu vaccine...
Novavax strikes $1.2B deal with Sanofi to develop COVID-flu combo vaccine
BenefitsPRO· 3 days agoNovavax signed a $1.2 billion licensing agreement with Sanofi that includes commercializing a...
Novavax signs multibillion-dollar deal with Sanofi to commercialize Covid vaccine, develop...
CNBC· 6 days agoThe licensing agreement will allow Novavax to lift its "going concern" warning, which it first...
Aaron Rodgers slammed over Vladimir Putin, Joe Biden remark
Newsweek· 20 hours agoAaron Rodgers has been slammed for his recent comments on President Joe Biden and Russian President...
One of the most shorted stocks on the market just leapt 99%, putting a ‘rib-crunching’ squeeze on...
Fortune· 5 days agoShares of the vaccine maker soared 99% Friday, after the company signed a $1.2 billion licensing agreement with Sanofi that includes commercializing a combined Covid-19 and flu</ ...
Canucks get Tyler Myers injury scare in Game 2 vs Oilers
ClutchPoints· 5 days agoThe Vancouver Canucks are hoping to gain a huge 2-0 series lead over the Edmonton Oilers. Game 2 has...
Moderna’s First Vaccine Was a Big Hit. Its Second Is a Let Down
Bloomberg via Yahoo Finance· 7 days ago(Bloomberg) -- Moderna Inc.’s pioneering Covid shot turned the company into a nearly $200 billion...
Novavax stock soars 120% as Sanofi deal 'kicks off a new chapter' By Investing.com
Investing.com· 6 days agoAccording to Novavax CEO John Jacobs, the partnership will enable the company to lift its "going...
Novavax stock jumps 50% as Sanofi deal kicks off turning point for struggling vaccine maker
CNBC· 3 days agoA vial labelled "Novavax V COVID-19 Vaccine" is seen in this illustration taken January 16, 2022....